Our Business

Altus Enterprises employs diverse R & D technologies to establish clinical development paths for biopharmaceuticals as well as diagnostic solutions for various diseases including COVID-19.

​​

The foundation of our approach is built on developing an innovative design space that integrates data science, analytical technologies and a robust regulatory science-based framework to develop therapeutics or diagnostics that is aimed at mitigation of risks from a clinical safety and efficacy perspective. Our approach is different from the conventional high-risk, high-cost R&D models. Through collaborative partnerships, we seek to bring diagnostics and life-saving therapies that are accessible and affordable to patients.